Characterization and biodistribution of recombinant and recombinant/chimeric constructs of monoclonal antibody B72. 3
Radiolabeled B72.3 has been administered both i.v. and i.p. in patients with colorectal and ovarian cancer as well as other carcinomas and has been shown to selectively bind to approximately 70-80% of metastatic lesions. Greater than 50% of the patients that have been treated with B72.3 have developed an immunological response to murine IgG after a single injection. In an attempt to minimize the immune response of these patients to the administered murine monoclonal antibody, we developed a recombinant form of the murine B72.3 as well as a recombinant/chimeric antibody, using the variable regions of the murine B72.3 and human heavy chain (gamma 4) and light chain (kappa) constant regions. We report here that both the recombinant B72.3 (rB72.3) and the recombinant/chimeric B72.3 (cB72.3(gamma 4)) IgGs maintain the tissue binding and idiotypic specificity of the native murine IgG. The native B72.3, rB72.3, and cB72.3(gamma 4) IgGs were radiolabeled and the biodistribution of these IgGs was studied in athymic mice bearing human colon carcinoma xenografts (LS-174T). Differences were observed between the cB72.3(gamma 4) and the native B72.3 in the percentage of injected dose/g that localized in the tumor. The somewhat lower absolute amounts of the cB72.3(gamma 4) in the tumor are mostly likely due to the observed more rapid clearance from the blood and body of the mouse as compared to the native B72.3 and rB72.3. All three forms (native B72.3, rB72.3, and cB72.3(gamma 4)) of the IgG, however, were able to localize the colon tumor with similar radiolocalization indices (percentage of injected dose/g in tumor divided by the percentage of injected dose/g in normal tissue).
- Research Organization:
- National Cancer Institute, Bethesda, MD (USA)
- OSTI ID:
- 6256278
- Journal Information:
- Cancer Res.; (United States), Journal Name: Cancer Res.; (United States) Vol. 49:7; ISSN CNREA
- Country of Publication:
- United States
- Language:
- English
Similar Records
Radioimmunolocalization of human carcinoma xenografts with B72. 3 second generation monoclonal antibodies
Advantage of dose fractionation in monoclonal antibody-targeted radioimmunotherapy
Related Subjects
550604 -- Medicine-- Unsealed Radionuclides in Therapy-- (1980-)
62 RADIOLOGY AND NUCLEAR MEDICINE
ANIMALS
ANTIBODIES
ANTIGENS
BODY
CARCINOMAS
CHEMICAL COMPOSITION
CLEARANCE
DIGESTIVE SYSTEM
DISEASES
DISTRIBUTION
EXPERIMENTAL NEOPLASMS
GASTROINTESTINAL TRACT
GLYCOPROTEINS
HAMSTERS
IMMUNE REACTIONS
INTESTINES
IODINE ISOTOPES
ISOTOPE APPLICATIONS
ISOTOPES
LARGE INTESTINE
MAMMALS
MICE
MONOCLONAL ANTIBODIES
NEOPLASMS
ORGANIC COMPOUNDS
ORGANS
PATIENTS
PROTEINS
RODENTS
SPECIFICITY
TISSUE DISTRIBUTION
TRACER TECHNIQUES
VERTEBRATES